Innoveren Scientific Inc. (IVRN)

OTCMKTS · Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Jul 17, 2025
-94.44%
Market Cap1.60K
Revenue (ttm)n/a
Net Income (ttm)-3.26M
Shares Out8.01M
EPS (ttm)-5.51
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume5,000
Average Volume46,358
Open0.0002
Previous Closen/a
Day's Range0.0002 - 0.0002
52-Week Rangen/a
Beta471.12
RSI33.92
Earnings DateAug 12, 2025

About Innoveren Scientific

Innoveren Scientific Inc., a medical bioscience company that develops technology in regenerative medicine for limb salvage. It is also developing immunotherapies for ovarian cancer, pancreatic cancer, and mesothelioma. The company was formerly known as H-CYTE, Inc. and changed its name to Innoveren Scientific Inc. in July 2023. The company is headquartered in Tampa, Florida. [Read more]

Industry Biotechnology
Sector Healthcare
CEO Michael Yurkowsky
Employees 2
Stock Exchange OTCMKTS
Ticker Symbol IVRN
Full Company Profile

Financial Performance

In 2022, Innoveren Scientific's revenue was $453,460, a decrease of -71.86% compared to the previous year's $1.61 million. Losses were -$10.30 million, 114.6% more than in 2021.

Financial Statements

News

Innoveren Scientific Announces 510(k) Submission for SkinDisc(TM) Lite

First Commercial Product Submission from Company's Robust Regenerative Medicine-Based Pipeline CINCINNATI, OH / ACCESSWIRE / March 6, 2024 / Innoveren Scientific Inc. (OTCQB:IVRN) ("Innoveren" or the ...

1 year ago - Accesswire

Innoveren Scientific Divests Device & Receives Capital Infusion

Proceeds to be used to complete corporate rebranding, accelerate acquisition pipeline, and attract additional investment TAMPA, FL / ACCESSWIRE / October 3, 2023 / Innoveren Scientific Inc. (OTCQB:IVR...

1 year ago - Accesswire